Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.24.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue:        
Product revenue, net $ 14,629 $ 15,279 $ 42,514 $ 44,405
Other revenue   19,260   19,519
Total revenue 14,629 34,539 42,514 63,924
Operating expenses        
Cost of goods sold - product revenue 5,285 6,429 18,642 20,645
Research and development 842 2,229 9,639 6,036
Selling, general and administrative 11,396 8,636 30,144 34,069
Loss on impairment of intangible assets       3,143
Total operating expenses 17,523 17,294 58,425 63,893
Income (loss) from operations (2,894) 17,245 (15,911) 31
Other expense (income)        
Interest income (188) (8) (566) (209)
Interest expense 758 268 1,869 1,674
Foreign exchange transaction losses 51 101 104 181
Gain on extinguishment of debt (1,125)   (1,125)  
Total other expense (income) (504) 361 282 1,646
Income (loss) before income taxes (2,390) 16,884 (16,193) (1,615)
Income tax expense   95   95
Net income (loss) $ (2,390) $ 16,789 $ (16,193) $ (1,710)
Net income (loss) per common share:        
Basic $ (0.12) $ 0.91 $ (0.80) $ (0.09)
Diluted $ (0.12) $ 0.80 $ (0.80) $ (0.09)
Weighted average number of common shares:        
Basic 20,537,794 18,416,368 20,137,942 18,078,437
Diluted 20,537,794 21,034,758 20,137,942 18,078,437